Geode Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,178
| Closed | -$158K | – | 4951 |
|
|
2022
Q4 | $158K | Sell |
14,178
-140,993
| -91% | -$1.57M | ﹤0.01% | 4214 |
|
|
2022
Q3 | $872K | Buy |
155,171
+33,231
| +27% | +$187K | ﹤0.01% | 3460 |
|
|
2022
Q2 | $528K | Sell |
121,940
-83,500
| -41% | -$362K | ﹤0.01% | 3732 |
|
|
2022
Q1 | $2.39M | Buy |
205,440
+4,006
| +2% | +$46.6K | ﹤0.01% | 3172 |
|
|
2021
Q4 | $3.68M | Buy |
201,434
+16,537
| +9% | +$302K | ﹤0.01% | 3063 |
|
|
2021
Q3 | $2.19M | Sell |
184,897
-26,998
| -13% | -$320K | ﹤0.01% | 3307 |
|
|
2021
Q2 | $3.64M | Buy |
211,895
+49,493
| +30% | +$851K | ﹤0.01% | 3078 |
|
|
2021
Q1 | $2.97M | Buy |
162,402
+28,836
| +22% | +$527K | ﹤0.01% | 3062 |
|
|
2020
Q4 | $2.51M | Buy |
133,566
+20,849
| +18% | +$392K | ﹤0.01% | 2959 |
|
|
2020
Q3 | $2.38M | Buy |
112,717
+193
| +0.2% | +$4.07K | ﹤0.01% | 2784 |
|
|
2020
Q2 | $3.25M | Buy |
112,524
+20,995
| +23% | +$606K | ﹤0.01% | 2564 |
|
|
2020
Q1 | $3.2M | Buy |
91,529
+21,038
| +30% | +$736K | ﹤0.01% | 2413 |
|
|
2019
Q4 | $1.72M | Buy |
+70,491
| New | +$1.72M | ﹤0.01% | 3077 |
|